Want to see FR:SIGHT full AI Analyst Report?
GenSight Biologics SA (SIGHT) Q2 2023 Earnings Report
FR:SIGHT Q2 2023 EPS Results
- Actual EPS
- -EUR 0.26
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.23
FR:SIGHT Q2 2023 Revenue Results
- Actual Revenue
- EUR 1.55M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- -49.31%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 07/26/2023
- Time
- TBA
- Conference Call
- Wednesday, July 26, 2023
FR:SIGHT Upcoming Earnings
GenSight Biologics SA's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
FR:SIGHT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | -0.03 | ― | ― |
| Sep 29, 2026 | 2026 (Q2) | ―-0.05 | -0.05 | 0.00% (+0.00) | |
| Mar 27, 2026 | 2025 (Q4) | ―-0.03 | -0.08 | 64.47% (+0.05) | |
| Sep 29, 2025 | 2025 (Q2) | ―-0.05 | -0.07 | 28.57% (+0.02) | |
| Mar 19, 2025 | 2024 (Q4) | ―-0.08 | -0.28 | 73.14% (+0.21) | |
| Oct 24, 2024 | 2024 (Q3) | ―- | -0.26 | ― | |
| Sep 23, 2024 | 2024 (Q2) | ―-0.07 | -0.26 | 73.08% (+0.19) | |
| Mar 22, 2024 | 2023 (Q4) | ―-0.28 | ― | ― | |
| Jul 26, 2023 | 2023 (Q2) | ―-0.26 | -0.23 | -13.04% (-0.03) | |
| Mar 24, 2023 | 2022 (Q4) | ―- | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
